Fexuclue

Search results

Advanced search

Scope

Title Contents All

Date

Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines

South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...

Aug 01, 2023 (Gmt+09:00)

language
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile

South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...

Mar 14, 2023 (Gmt+09:00)

language
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials

Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...

Feb 28, 2023 (Gmt+09:00)

language
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...

Feb 06, 2023 (Gmt+09:00)

language
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries

South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...

Dec 14, 2022 (Gmt+09:00)

language

Stay Korea Savvy
with our newsletters

Fill in the information to subscribe to our newsletter and you can also getunlimited access to the latest intelligence on Korean asset owners.